These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10566076)

  • 1. Can HIV infection be prevented with a vaccine?
    Joy AK; Dale CJ; Kent SJ
    Drugs R D; 1999 Jun; 1(6):431-40. PubMed ID: 10566076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV gp160 vaccine gene therapy (Wyeth-Lederle Vaccines-Malvern).
    Drugs R D; 1999 Jun; 1(6):451-2. PubMed ID: 10566081
    [No Abstract]   [Full Text] [Related]  

  • 3. Challenges in the development of an HIV-1 vaccine.
    Barouch DH
    Nature; 2008 Oct; 455(7213):613-9. PubMed ID: 18833271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for AIDS vaccines.
    Stott EJ; Schild GC
    J Antimicrob Chemother; 1996 May; 37 Suppl B():185-98. PubMed ID: 8818840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AIDS vaccine: efficacy, safety and ethics.
    Veljkovic V; Veljkovic N; Glisic S; Ho MW
    Vaccine; 2008 Jun; 26(24):3072-7. PubMed ID: 18164521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus antibodies and the vaccine problem.
    Chiodi F; Weiss RA
    J Intern Med; 2014 May; 275(5):444-55. PubMed ID: 24581142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV gp120 vaccine - VaxGen: AIDSVAX, AIDSVAX B/B, AIDSVAX B/E, HIV gp120 vaccine - Genentech, HIV gp120 vaccine AIDSVAX - VaxGen, HIV vaccine AIDSVAX - VaxGen.
    Adis International Ltd
    Drugs R D; 2003; 4(4):249-53. PubMed ID: 12848591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Particle-based vaccines for HIV-1 infection.
    Young KR; Ross TM
    Curr Drug Targets Infect Disord; 2003 Jun; 3(2):151-69. PubMed ID: 12769792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventive HIV-1 vaccines: where are we going?
    Kent SJ
    Int J STD AIDS; 1998 Dec; 9(12):715-9. PubMed ID: 9874116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV preventive vaccines. Progress to date.
    Esparza J; Osmanov S; Heyward WL
    Drugs; 1995 Nov; 50(5):792-804. PubMed ID: 8586027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV vaccine vCP205. ALVAC-HIV vCP205, ALVAC vCP205.
    Drugs R D; 1999 Jun; 1(6):459-60. PubMed ID: 10566084
    [No Abstract]   [Full Text] [Related]  

  • 12. Biological considerations in the development of a human immunodeficiency virus vaccine.
    Nathanson N; Mathieson BJ
    J Infect Dis; 2000 Aug; 182(2):579-89. PubMed ID: 10915092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review.
    Girard MP; Osmanov S; Assossou OM; Kieny MP
    Vaccine; 2011 Aug; 29(37):6191-218. PubMed ID: 21718747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospects for vaccine protection against HIV-1 infection and AIDS.
    Letvin NL; Barouch DH; Montefiori DC
    Annu Rev Immunol; 2002; 20():73-99. PubMed ID: 11861598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV gp160 vaccine (Immuno AG).
    Drugs R D; 1999 Jun; 1(6):449-50. PubMed ID: 10566080
    [No Abstract]   [Full Text] [Related]  

  • 16. HIV gp120 vaccine (Chiron).
    Drugs R D; 1999 Jun; 1(6):445-7. PubMed ID: 10566078
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV Vaccination: A Roadmap among Advancements and Concerns.
    Trovato M; D'Apice L; Prisco A; De Berardinis P
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29671786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current issues in the development of a vaccine to prevent human immunodeficiency virus: insights from the society of infectious diseases pharmacists.
    Sahloff EG
    Pharmacotherapy; 2005 May; 25(5):741-7. PubMed ID: 15899735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-envelope HIV vaccine safety and immunogenicity in small animals and chimpanzees.
    Lockey TD; Slobod KS; Caver TE; D'Costa S; Owens RJ; McClure HM; Compans RW; Hurwitz JL
    Immunol Res; 2000; 21(1):7-21. PubMed ID: 10803879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress and obstacles in the development of an AIDS vaccine.
    Letvin NL
    Nat Rev Immunol; 2006 Dec; 6(12):930-9. PubMed ID: 17124514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.